Luo and colleagues further showed that the circulating miR-103 family are potential biomarkers for T2D through targeting genes coding for caveolin 1 (CAV-1) and secreted frizzled-related protein 4 (SFRP4) (61). This evidence concerns the gene SFRP4 and type 2 diabetes mellitus.